Found 0 matching trials
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
PHASE3RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Location
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol
NAThe purpose of study is to compare the effectiveness of the Day-5 fixed adm...
Location
Multiple Locations
GP Extended Action Triptorelin
PHASE4The purpose of this study is to demonstrate that treatment with a 6-monthly...
Location
The Crouch Oak Family Practice
An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
N/AAim to investigate the efficacy of follitropin alpha biosimilar therapy (Pr...
Location
Center for reproductive medicine, Barnaul
Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes
PHASE4The goal of this randomized clinical trial is to compare the effects of two...
Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)
NAExploratory, prospective, randomized, comparative, open trial with control ...
Location
Instituto Bernabeu
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
PHASE2This phase II trial studies how well apalutamide and gonadotropin-releasing...
Location
M D Anderson Cancer Center
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer
N/AThis is an observational study in which patient data from the past on men w...
Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome
NAThis is a prospective, randomized, proof-of-concept study, designed to comp...
Premenopausal Endocrine Responsive Chemotherapy Trial
PHASE3The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Location
National Institute of Oncology